Authors:
Beresford, SA
Davies, MA
Gallick, GE
Donato, NJ
Citation: Sa. Beresford et al., Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PC-3 prostate cancer cells, J INTERF CY, 21(5), 2001, pp. 313-322
Authors:
Shin, DM
Donato, NJ
Perez-Soler, R
Shin, HJC
Wu, JY
Zhang, P
Lawhorn, K
Khuri, FR
Glisson, BS
Myers, J
Clayman, G
Pfister, D
Falcey, J
Waksal, H
Mendelsohn, J
Hong, WK
Citation: Dm. Shin et al., Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer, CLIN CANC R, 7(5), 2001, pp. 1204-1213
Citation: Yh. Ling et al., Sensitivity to topoisomerase I inhibitors and cisplatin is associated withepidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines, CANC CHEMOT, 47(6), 2001, pp. 473-480
Authors:
Leroux, E
Auzenne, E
Weidner, D
Wu, ZY
Donato, NJ
Klostergaard, J
Citation: E. Leroux et al., Febrile and acute hyperthermia enhance TNF-induced necrosis of murine L929fibrosarcoma cells via caspase-regulated production of reactive oxygen intermediates, J CELL PHYS, 187(2), 2001, pp. 256-263
Authors:
Donato, NJ
Wu, JY
Zhang, L
Kantarjian, H
Talpaz, M
Citation: Nj. Donato et al., Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulatingfactor receptor beta-chain in BCR-ABL(+) human leukemic cells: associationwith loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibition, BLOOD, 97(9), 2001, pp. 2846-2853
Citation: Nj. Donato et M. Talpaz, Clinical use of tyrosine kinase inhibitors: Therapy for chronic myelogenous leukemia and other cancers, CLIN CANC R, 6(8), 2000, pp. 2965-2966
Authors:
Donato, NJ
Perez, M
Kang, H
Siddik, ZH
Ling, YH
Perez-Soler, R
Citation: Nj. Donato et al., EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity, CLIN CANC R, 6(1), 2000, pp. 193-202
Authors:
Mujoo, K
Zhang, L
Klostergaard, J
Donato, NJ
Citation: K. Mujoo et al., Emergence of cisplatin-resistant cells from the OVCAR-3 ovarian carcinoma cell line with p53 mutations, altered tumorigenicity, and increased apoptotic sensitivity to p53 gene replacement, INT J GYN C, 10(2), 2000, pp. 105-114
Citation: M. Perez et al., Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor, ONCOGENE, 18(4), 1999, pp. 967-978